Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
Journal of Medical Virology
|
October 9, 2015
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance
Aintzane Zabaleta, Jose-Ignacio Riezu-Boj, Esther Larrea, et al.
Clinics in Liver Disease
|
October 1, 2023
What Is the Current Status of Hepatitis B Virus Viro-Immunology?
Carolina Boni, Marzia Rossi, Ilaria Montali, et al.
Frontiers in Oncology
|
December 23, 2024
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Graziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC
Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, et al.
Frontiers in Oncology
|
August 8, 2022
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Graziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 7, 2017
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma
Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra, et al.
Hepatology (Baltimore, Md.)
|
September 12, 2015
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B
Carolina Boni, Pietro Lampertico, Lavinia Talamona, et al.
Immunotherapy
|
June 9, 2018
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab
Francesco Facchinetti, Michele Veneziani, Sebastiano Buti, et al.
Journal of Hepatology
|
April 17, 2013
Treatment optimization and prediction of HCV clearance in patients with acute HCV infection
Alessandra Mangia, Rosanna Santoro, Massimiliano Copetti, et al.
Frontiers in Immunology
|
November 21, 2025
TGF-β-driven NK Cells plasticity in hepatocellular carcinoma
Valentina Reverberi, Anna Montali, Andrea Vecchi, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
Journal of Medical Virology
|
October 9, 2015
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance
Aintzane Zabaleta, Jose-Ignacio Riezu-Boj, Esther Larrea, et al.
Clinics in Liver Disease
|
October 1, 2023
What Is the Current Status of Hepatitis B Virus Viro-Immunology?
Carolina Boni, Marzia Rossi, Ilaria Montali, et al.
Frontiers in Oncology
|
December 23, 2024
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Graziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 16, 2019
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC
Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, et al.
Frontiers in Oncology
|
August 8, 2022
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Graziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 7, 2017
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma
Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra, et al.
Hepatology (Baltimore, Md.)
|
September 12, 2015
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B
Carolina Boni, Pietro Lampertico, Lavinia Talamona, et al.
Immunotherapy
|
June 9, 2018
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab
Francesco Facchinetti, Michele Veneziani, Sebastiano Buti, et al.
Journal of Hepatology
|
April 17, 2013
Treatment optimization and prediction of HCV clearance in patients with acute HCV infection
Alessandra Mangia, Rosanna Santoro, Massimiliano Copetti, et al.
Frontiers in Immunology
|
November 21, 2025
TGF-β-driven NK Cells plasticity in hepatocellular carcinoma
Valentina Reverberi, Anna Montali, Andrea Vecchi, et al.
Page
of 12